Get startedLog in
    Picture of Santhera Pharmaceuticals Holding AG logo

    SANN — Santhera Pharmaceuticals Holding AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Santhera Says UK's MHRA Renews EAMS Opinion For Idebenone

    Picture of Santhera Pharmaceuticals Holding AG logoSanthera Pharmaceuticals Holding AG
    23/06/2020 06:06
    June 23 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
 SANN.S :
    * UK'S MHRA RENEWS EAMS SCIENTIFIC OPINION FOR SANTHERA'S
IDEBENONE IN DUCHENNE MUSCULAR DYSTROPHY
    * EXPECTS AN OPINION BY COMMITTEE FOR MEDICINAL PRODUCTS FOR
HUMAN
USE (CHMP) IN Q4 2020

Source text for Eikon:  ID:nGNE7wFgzk 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Santhera Pharmaceuticals Holding AG

    See all news